1-5 of 5
Randi E. Isaacs, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple Myeloma

Alfred L. Garfall, MD, Adam D. Cohen, MD, Simon F Lacey, PhD, Lifeng Tian, PhD, Wei-Ting Hwang, PhD, Dan T. Vogl, MD, Adam Waxman, MD, Eric Lancaster, MD, Anne Marie Nelson, Regina Ferthio, Andrew Fesnak, MD, Anne Lamontagne, Andrea Brennan, Jamie Guilliams, Whitney Lynn Gladney, PhD, J. Joseph Melenhorst, PhD, Regina M Young, PhD, Don L. Siegel, MD PhD, Bruce L Levine, PhD, Jennifer Brogdon, PhD, Randi E. Isaacs, MD, Carl H June, MD, Michael C. Milone, Edward A. Stadtmauer, MD FACP
Journal: Blood
Blood (2019) 134 (Supplement_1): 1863.
https://doi.org/10.1182/blood-2019-131515
Published: 2019
Journal Articles

Prospective Clinical Trial of Anti-CD19 CAR T Cells in Combination with Ibrutinib for the Treatment of Chronic Lymphocytic Leukemia Shows a High Response Rate

Saar I. Gill, MDPhD, Vanessa Vides, BS, Noelle V. Frey, MD, Susan Metzger, BSN, Megan O'Brien, Elizabeth Hexner, MD, Anthony R. Mato, MDMSCE, Simon F Lacey, PhD BS, J. Joseph Melenhorst, PhD, Edward Pequignot, MSc, Whitney Lynn Gladney, PhD, Wei-Ting Hwang, PhD, Anne Lamontagne, Megan Davis, PhD, John C. Byrd, MD, Stephen J. Schuster, MD, Don L. Siegel, MD PhD, Randi E. Isaacs, MD, Carl H June, MD, David L. Porter, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 298.
https://doi.org/10.1182/blood-2018-99-115418
Published: 2018
Journal Articles

Treating Relapsed / Refractory (RR) AML with Biodegradable Anti-CD123 CAR Modified T Cells

Katherine D Cummins, BMBS, Noelle Frey, MD, Anne Marie Nelson, Aliza Schmidt, MS, Selina Luger, MD FRCPC, Randi E. Isaacs, MD, Simon F Lacey, PhD BS, Elizabeth Hexner, MDMS, J. Joseph Melenhorst, PhD, Carl H June, MD, David L Porter, MD, Saar I Gill, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1359.
https://doi.org/10.1182/blood.V130.Suppl_1.1359.1359
Published: 2017
Journal Articles

Safety and Efficacy of B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) with Cyclophosphamide Conditioning for Refractory Multiple Myeloma (MM)

Adam D. Cohen, MD, Alfred L. Garfall, MD, Edward A. Stadtmauer, MD FACP, Simon F Lacey, PhD BS, Eric Lancaster, Dan T. Vogl, MD, Brendan M Weiss, MD, David E Ambrose, BS, Anne Marie Nelson, Fang Chen, PhD, Gabriela Plesa, MD, Irina Kulikovskaya, Vanessa Gonzalez, Minnal Gupta, Regina M Young, PhD, Karen Dengel, BSN, RN, Laura O'keefe, Samantha Le, Celeste Richardson, PhD, Randi E. Isaacs, MD, J. Joseph Melenhorst, PhD, Bruce L Levine, PhD, Carl H June, MD, Michael C. Milone, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 505.
https://doi.org/10.1182/blood.V130.Suppl_1.505.505
Published: 2017
Journal Articles

B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) for Multiple Myeloma (MM): Initial Safety and Efficacy from a Phase I Study

Adam D. Cohen, MD, Alfred L. Garfall, MD, Edward A Stadtmauer, MD, Simon Francis Lacey, PhD BS, Eric Lancaster, MD PhD, Dan T. Vogl, MD, Karen Dengel, BSN, RN, David E Ambrose, BS, Fang Chen, PhD, Gabriela Plesa, PhD, Irina Kulikovskaya, PhD, Vanessa E Gonzalez, M.B.A, Minnal Gupta, MSc, Regina M Young, PhD, Tenesia Carey, Regina Ferthio, Brendan M. Weiss, MD, Celeste Richardson, PhD, Randi E. Isaacs, MD, J. Joseph Melenhorst, PhD, Bruce L. Levine, PhD, Carl H June, MD, Michael C. Milone, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1147.
https://doi.org/10.1182/blood.V128.22.1147.1147
Published: 2016